Transcript ppt

Rhinitis
April 10, 2006
THE NOSE
CT of THE NOSE
The inside of THE NOSE
Therapeutic Options Allergic Rhinitis
•
Antihistamines
•
Decongestants
•
Anticholinergics
•
Corticosteroids
AAAAI. The Allergy Report. 2000.
Dykewicz M et al. Ann Allergy Asthma Immunol. 1998;81:478–518.

Cromones/mast
cell stabilizers

Leukotriene
receptor
antagonists

Immunotherapy
Therapeutic Options Allergic Rhinitis
•
Antihistamines
•
Decongestants
•
Anticholinergics
•
Corticosteroids
AAAAI. The Allergy Report. 2000.
Dykewicz M et al. Ann Allergy Asthma Immunol. 1998;81:478–518.

Cromones/mast
cell stabilizers

Leukotriene
receptor
antagonists

Immunotherapy
Pseudoephedrine and HR
Pseudoephedrine and SBP
Pseudoephedrine and DBP
Every Patient is Different
Therapeutic Options Allergic Rhinitis
•
Antihistamines
•
Decongestants
•
Anticholinergics
•
Corticosteroids
AAAAI. The Allergy Report. 2000.
Dykewicz M et al. Ann Allergy Asthma Immunol. 1998;81:478–518.

Cromones/mast
cell stabilizers

Leukotriene
receptor
antagonists

Immunotherapy
Intranasal Corticosteroids in
Allergic Rhinitis: An Overview
Benefits
Drawbacks
• Are first-line therapy for
persistent allergic rhinitis
• May cause nasal irritation
and/or bleeding
• Relieve all symptoms
– Sneezing
– Nasal itching
– Rhinorrhea
• Patient compliance
• Patient concerns about
steroids
– Nasal congestion
• Minimal side effects
Urval KR. Primary Care. 1998;25(3):649-662.
Suonpaa J. Ann Med. 1996;28:17-22.
Dykewicz MS, Fineman S. Ann Allergy Asthma Immunol. 1998;81:463-468.
INS or NSA
Therapeutic Options Allergic Rhinitis
•
Antihistamines
•
Decongestants
•
Anticholinergics
•
Corticosteroids
AAAAI. The Allergy Report. 2000.
Dykewicz M et al. Ann Allergy Asthma Immunol. 1998;81:478–518.

Cromones/mast
cell stabilizers

Leukotriene
receptor
antagonists

Immunotherapy
LTRA in Allergic Rhinitis
All Evidence is Not the Same
Therapeutic Options Allergic Rhinitis
•
Antihistamines
•
Decongestants
•
Anticholinergics
•
Corticosteroids
AAAAI. The Allergy Report. 2000.
Dykewicz M et al. Ann Allergy Asthma Immunol. 1998;81:478–518.

Cromones/mast
cell stabilizers

Leukotriene
receptor
antagonists

Immunotherapy
Subcutaneous Immunotherapy
(Hyposensitization)
• Mechanism of action = Unknown (may shift
immune response from TH2- to TH1-response
to allergen)
• Efficacy:
Demonstrated in AR
Only disease-modifying therapy for AR
• Usage: In patients who do not respond
adequately to pharmacotherapy
• Side effects: local reactions, anaphylaxis
AAAAI. The Allergy Report. 2000. Available at: http://www.theallergyreport.org/reportindex.html
Types of Rhinitis
• Allergic
– Seasonal or Perennial
– Intermittent or Persistent
• Non Allergic
– Vasomotor
– Infectious
• Viral or Bacterial
– Drug induced
• Antihypertensives, Afrin
– Hormonal
• Pregnancy, Hypothyroid
– NARES, Atrophic, Anatomic